TACC3 and urinary bladder cancer: To investigate the biologic activities of TACC3 in bladder cancer, we first examined the effect of siRNA-induced reduction of TACC3 by western blot (Fig. 2a) and Real-time Quantitative Polymerase Chain Reaction qRT-PCR (Fig. 2b).